Lucia Quinn - UFP Technologies Director
| UFPT Stock | USD 228.99 1.13 0.50% |
Director
Ms. Lucia Luce Quinn is an Independent Director of UFP Technologies, Inc., Ms. Quinn has served as a director of the Company since December 2013. In early 2019, Ms. Quinn accepted a position as Chief People Officer at WuXi NextCODE, an integrated global life sciences informatics company that serves the leading population genomics, precision medicine, diagnostics and wellness initiatives and enterprises with the most proven and widely used technology for organizing, mining and sharing genome sequence data. In October 2016, Ms. Quinn accepted the position of Strategic Advisor at Shepley Bulfinch, a national architecture firm. Previously, Ms. Quinn served as Chief People Officer of Forrester Research, Inc., a 340 million global research and advisory firm from June 2013 until 2018. From June 2012 through May 2013, Ms. Quinn consulted with Truepoint Partners, a strategic planning and organization development consulting firm. From June 2010 through April 2012 Ms. Quinn was Senior Vice President, Global Human Resources and Corporationrationrate Affairs for Convatec, Inc., a 1.6 billion medical device and products company. From March 2005 through September 2009 Ms. Quinn was Executive Vice President, BSC Global Human Resources at Boston Scientific, an 8 billion medical solutions provider. Prior to that, Ms. Quinn served in various leadership and operations capacities at Quest Diagnostics, AlliedSignalHoneywell, Digital Equipment Corporationration and Westinghouse Electric Corporationration Ms. Quinn also served as a trustee of Simmons College from 1996 to 2011, including chairing the Technology and Executive Compensation committees and serving as Chair of the Board of Trustees for five years. Ms. Quinn possesses particular knowledge and experience in human resources, strategic planning and leadership consulting for complex organizations that strengthen the Board collective qualifications, skills, and experience. since 2013.
| Age | 64 |
| Tenure | 11 years |
| Address | 100 Hale Street, Newburyport, MA, United States, 01950-3504 |
| Phone | 978 352 2200 |
| Web | https://www.ufpt.com |
UFP Technologies Management Efficiency
The company has return on total asset (ROA) of 0.098 % which means that it generated a profit of $0.098 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1716 %, meaning that it created $0.1716 on every $100 dollars invested by stockholders. UFP Technologies' management efficiency ratios could be used to measure how well UFP Technologies manages its routine affairs as well as how well it operates its assets and liabilities. At this time, UFP Technologies' Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.12 in 2024, whereas Return On Capital Employed is likely to drop 0.1 in 2024. At this time, UFP Technologies' Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 424.3 M in 2024, whereas Non Current Liabilities Other is likely to drop slightly above 5.2 M in 2024.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Bryan Cressey | Select Medical Holdings | 71 | |
| Daniel Thomas | Select Medical Holdings | 62 | |
| Jonathan Wheeler | CryoCell International | 55 | |
| Malene Davis | The Ensign Group | 55 | |
| Antoinette Hubenette | The Ensign Group | 67 | |
| Ernest Burgess | National HealthCare | 79 | |
| Richard LaRoche | National HealthCare | 74 | |
| Marilyn Tavenner | Select Medical Holdings | 69 | |
| James Dalton | Select Medical Holdings | 73 | |
| Nancy Schlichting | Encompass Health Corp | 66 | |
| Leopold Swergold | Select Medical Holdings | 77 | |
| Katherine Davisson | Select Medical Holdings | 53 | |
| Christopher Reidy | Encompass Health Corp | 64 | |
| Harold Paz | Select Medical Holdings | 62 | |
| Arthur Ellis | CryoCell International | N/A | |
| John Maupin | Encompass Health Corp | 73 | |
| Daren Shaw | The Ensign Group | 61 | |
| Ann Blouin | The Ensign Group | 65 | |
| Lawrence Tucker | National HealthCare | 75 | |
| James Ely | Select Medical Holdings | 63 | |
| Brian Sheehy | CryoCell International | N/A | |
Management Performance
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.098 |
UFP Technologies Leadership Team
Elected by the shareholders, the UFP Technologies' board of directors comprises two types of representatives: UFP Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UFP. The board's role is to monitor UFP Technologies' management team and ensure that shareholders' interests are well served. UFP Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, UFP Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christopher Litterio, Senior Vice President of Human Resources, General Counsel, Secretary | ||
| Jeffrey Bailly, Chairman, CEO and Pres | ||
| Steven Cardin, VP MedTech | ||
| William Smith, Sr. VP of Operations | ||
| Marc Kozin, Independent Director | ||
| David Stevenson, Independent Director | ||
| Cynthia Feldmann, Director | ||
| Jason Holt, Chief Officer | ||
| Daniel Shaw, VP of RandD | ||
| Ronald Lataille, CFO, Sr. VP, Treasurer and Secretary | ||
| Robert Pierce, Independent Director | ||
| Daniel Croteau, Director | ||
| Thomas Oberdorf, Independent Director | ||
| Mitchell Rock, Sr. VP of Sales and Marketing | ||
| Kenneth Gestal, Director | ||
| Lucia Quinn, Director | ||
| Christopher Esq, Secretary Counsel | ||
| Steve Cardin, VP MedTech | ||
| Daniella Mehalik, Vice Finance |
UFP Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is UFP Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.098 | ||||
| Profit Margin | 0.11 % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 1.79 B | ||||
| Shares Outstanding | 7.64 M | ||||
| Shares Owned By Insiders | 6.76 % | ||||
| Shares Owned By Institutions | 96.40 % | ||||
| Number Of Shares Shorted | 209.82 K | ||||
| Price To Earning | 65.63 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| LTC | Litecoin | |
| STETH | Staked Ether | |
| LINK | Chainlink |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UFP Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy UFP Stock please use our How to Invest in UFP Technologies guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for UFP Stock analysis
When running UFP Technologies' price analysis, check to measure UFP Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UFP Technologies is operating at the current time. Most of UFP Technologies' value examination focuses on studying past and present price action to predict the probability of UFP Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UFP Technologies' price. Additionally, you may evaluate how the addition of UFP Technologies to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is UFP Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UFP Technologies. If investors know UFP will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UFP Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.369 | Earnings Share 5.83 | Revenue Per Share 52.475 | Quarterly Revenue Growth 0.112 | Return On Assets 0.098 |
The market value of UFP Technologies is measured differently than its book value, which is the value of UFP that is recorded on the company's balance sheet. Investors also form their own opinion of UFP Technologies' value that differs from its market value or its book value, called intrinsic value, which is UFP Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UFP Technologies' market value can be influenced by many factors that don't directly affect UFP Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UFP Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if UFP Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UFP Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.